5-Bromopyrazine-2-carboxylic acid → HCID 86676769, 화합물
반응식
[Br:1][C:2]1[N:3]=[CH:4][C:5]([C:8]([OH:10])=O)=[N:6][CH:7]=1.[CH:11]1([C:14]2[CH:15]=[C:16]([CH3:26])[C:17]([N:20]3[CH2:25][CH2:24][NH:23][CH2:22][CH2:21]3)=[N:18][CH:19]=2)[CH2:13][CH2:12]1>>[Br:1][C:2]1[N:3]=[CH:4][C:5]([C:8]([N:23]2[CH2:24][CH2:25][N:20]([C:17]3[C:16]([CH3:26])=[CH:15][C:14]([CH:11]4[CH2:12][CH2:13]4)=[CH:19][N:18]=3)[CH2:21][CH2:22]2)=[O:10])=[N:6][CH:7]=1참가 물질
3
실험 절차
Using 5-bromopyrazine-2-carboxylic acid (1 g) and 1-(5-cyclopropyl-3-methylpyridin-2-yl)piperazine (1.07 g) described in Preparation Example 83 and by the reaction and treatment in the same manner as in Preparation Example 118, the title compound (1.3 g) was obtained.
후처리
- customdescribed in Preparation Example 83 and by the reaction and treatment in the same manner as in Preparation Example 118
출처 및 근거
- ORD 기록
- ord-b7b2fca0d1164dc8ab30fd4099a47bfa
- 출처 데이터셋
- uspto-grants-2014_08
- 특허 번호
- US08816079B2
반응 노트
불러오는 중…